<DOC>
	<DOCNO>NCT01420562</DOCNO>
	<brief_summary>The goal study calculate pharmacokinetic parameter evaluate trough level posaconazole reach patient different stage mucositis , due chemotherapy total body irradiation .</brief_summary>
	<brief_title>Pharmacokinetics Posaconazole Allogeneic Transplant Patients With Mucositis</brief_title>
	<detailed_description />
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Posaconazole</mesh_term>
	<criteria>Patients receive allogeneic stem cell transplantation Treated prophylactic posaconazole : oral suspension ( 200mg three time daily ) tablet ( 300mg daily ) prevent invasive fungal infection Gastroparesis Vomiting diarrhea within 2 hour intake posaconazole Concomitant administration potent inducer enzyme UGT1A4 : carbamazepine , phenytoin , phenobarbital , rifabutin , rifampicin , ... Age 18 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>allogeneic HSCT</keyword>
	<keyword>posaconazole</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>mucositis</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>